Form4insider filings, from the source

SEC Form 4 · accession 0001547522-16-000255

IMMUCELL CORP /DE/ · ICCC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Joseph H Crabb
Officer — VP & Chief Scientific Officer · Director
Period of report
Jul 7, 2016
Accepted (ET)
Jul 7, 2016 · 4:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811641

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, par value $0.10 per shareJul 6, 2016S900$6.60D108,837D
Common Stock, par value $0.10 per shareJul 6, 2016S300$6.585D108,537D
Common Stock, par value $0.10 per shareJul 6, 2016S300$6.58D108,237D
Common Stock, par value $0.10 per shareJul 6, 2016S300$6.57D107,937D
Common Stock, par value $0.10 per shareJul 6, 2016S326$6.5701D107,611D
Common Stock, par value $0.10 per shareJul 6, 2016S300$6.59D107,311D
Common Stock, par value $0.10 per shareJul 7, 2016S6$6.59D107,305D
Common Stock, par value $0.10 per shareJul 7, 2016S200$6.53D107,105D
Common Stock, par value $0.10 per shareJul 7, 2016S59$6.55D107,046D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses